Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Fish oil, lard and soybean oil differentially shape gut microbiota of middle-aged rats. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 826 Pub: 2017 Apr 11 Epub: 2017 Apr 11 Authors Li H , Zhu Y , Zhao F , Song S , Li Y , Xu X , Zhou G , Li C , |
|
|
Fish Oil Ameliorates Vibrio parahaemolyticus Infection in Mice by Restoring Colonic Microbiota, Metabolic Profiles, and Immune Homeostasis. β
Go to Publication β
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 18 Pages: 6920-6934 Pub: 2023 May 10 Epub: 2023 Apr 26 Authors Deng Y , Wang R , Li X , Tan X , Zhang Y , Gooneratne R , Li J , |
|
|
Fish Oil Ameliorates Vibrio parahaemolyticus Infection in Mice by Restoring Colonic Microbiota, Metabolic Profiles, and Immune Homeostasis. β
Go to Publication β
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 18 Pages: 6920-6934 Pub: 2023 May 10 Epub: 2023 Apr 26 Authors Deng Y , Wang R , Li X , Tan X , Zhang Y , Gooneratne R , Li J , |
|
|
Docosahexaenoic acid-rich fish oil alleviates hepatic steatosis in association with regulation of gut microbiome in ob/ob mice. β
Go to Publication β
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 157 Issue Pages: 111373 Pub: 2022 Jul Epub: 2022 May 16 Authors Al-Bulish MSM , Cao W , Yang R , Wang Y , Xue C , Tang Q , |
|
|
Fish oil-based lipid emulsion alleviates parenteral nutrition-associated liver diseases and intestinal injury in piglets. β
Go to Publication β
JPEN. Journal of parenteral and enteral nutrition (JPEN J Parenter Enteral Nutr ) Vol: 46 Issue 3 Pages: 709-720 Pub: 2022 Mar Epub: 2021 Sep 6 Authors Chen S , Xiao Y , Liu Y , Tian X , Wang W , Jiang L , Wu W , Zhang T , Cai W , Wang Y , |
|
|
Investigating the potential of fish oil as a nutraceutical in an animal model of early life stress. β
Go to Publication β
Nutritional neuroscience (Nutr Neurosci ) Vol: 25 Issue 2 Pages: 356-378 Pub: 2022 Feb Epub: 2020 Jul 31 Authors Egerton S , Donoso F , Fitzgerald P , Gite S , Fouhy F , Whooley J , Dinan TG , Cryan JF , Culloty SC , Ross RP , Stanton C , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
